http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2184445-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9433d383d1922b3df0ca6c182c7d3925
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D273-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D273-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D273-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395
filingDate 1986-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49ab7ce4c2c59b8014d90ecdcb0cf547
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad010b060a12dc3b961b490359a7765e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5802a8ce284e999cb81942a244ddee86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10aeaca4b4a5fbe70887639aed3a22ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed74c8934b4da083b959936beb9e5696
publicationDate 1987-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-2184445-A
titleOfInvention Optically active 2-chloro-12-(3-dimethylamino-2-methylpropyl)-12H- dibenzo[d,g][1,3,6]dioxazocines and a process for the preparation thereof
abstract Optically active 2-chloro-12-(3-dimethylamino-2-methylpropyl)- 12H-dibenzo-[d,g][1,3,6]dioxazocines of the formulan n<IMAGE>n and pharmaceutically acceptable acid addition salts thereof, are especially active against Parkinson's disease. n<??>The optically active enantiomers are prepared by n n  a) resolving the racemic 2-chloro-1 2-(3-dimethylamino-2-methylpropyl)-12H-dibenzo[d,g][1,3,6]- dioxazocine with an optically active organic acid and separating the enantiomers; or n  b) dissolving the racemic 2-chloro-1 2-(3-dimethylamino-2-methylpropyl)-12H-dibenzo[d,g]- [1,3,6]dioxazocine in an organic solvent, crystallizing and isolating one of the enantiomers, optionally dissolving additional racemic 2-chloro-1 2-(3-dimethylamino-2-methylpropyl)-12H- dibenzo[d,g][1,3,6]dioxazocine in the mother liqueur obtained and crystallizing and isolating the other enantiomer, and, if desired, repeating the whole process.
priorityDate 1985-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408499458
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119400
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5534
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419496428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557670
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490743
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419529841
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419587468
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70912
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1303
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447315
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419589691
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422976921
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129812
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419569594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21910764
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6451481
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415827617
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID499

Total number of triples: 45.